Evofem Biosciences's total assets for Q2 2025 were $14.38M, an increase of 11.69% from the previous quarter. EVFM total liabilities were $84.00M for the fiscal quarter, a 1.86% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.